BullFrog AI Announces Licensing Agreement with Johns Hopkins University for Oncology Asset

Author's Avatar
Apr 18, 2023

Mebendazole prodrug license further expands the Company’s development pipeline, which includes a Phase 2 ready novel formulation of mebendazole for cancer treatment